Accelerating healthcare innovation: the role of Artificial intelligence and digital health technologies in critical path institute's public‐private partnerships.

This article discusses the role of Artificial Intelligence (AI) and Digital Health Technologies (DHTs) in drug development and the need for a harmonized approach to assess and implement these technologies. The Critical Path Institute (C-Path) is highlighted as a neutral entity that can address the pivotal roles of AI and DHTs in drug development through its competencies and infrastructure. C-Path's core competencies include data management and standards, modeling and analytics, biomarkers, clinical outcome assessments, and regulatory science. The article emphasizes C-Path's expertise in AI and DHTs and its ability to drive impactful advancements in the field through collaboration and innovation. [Extracted from the article]